Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In advanced colorectal cancer [21] and p53-inactivated lung tumors [22], diminished expression of DDX3 was observed, correlating with poor prognosis in patients, while in vitro experiments, loss of DDX3 promoted soft-agar growth and invasion
Your iron infusion claim will most likely be denied outright by your payer
The administration of a synthetic peptide (FOXO4-DRI = FOXO4-D-Retro-Inverso) to avoid the interaction between FOXO4 and p53 leads to a decrease of irradiated-induced senescent fibroblasts viability
How to Use
US$ 25.86
US$ 21.55
US$ 23.74
